|
US2021123097A1
|
|
Methods for 3' overhang repair
|
|
WO2021072275A1
|
|
Use of cell free bacterial nucleic acids for detection of cancer
|
|
US2021115502A1
|
|
Compositions and methods for analyzing cell-free dna in methylation partitioning assays
|
|
US2021017605A1
|
|
Methods and systems for improving patient monitoring after surgery
|
|
WO2020176775A1
|
|
Computational modeling of loss of function based on allelic frequency
|
|
WO2020176659A1
|
|
Methods and systems for determining the cellular origin of cell-free dna
|
|
US2020248272A1
|
|
Compositions and methods for isolating cell-free dna
|
|
WO2020132628A1
|
|
Methods, compositions, and systems for improving recovery of nucleic acid molecules
|
|
US2020199685A1
|
|
Determination of a physiological condition with nucleic acid fragment endpoints
|
|
WO2020092807A1
|
|
Methods, compositions and systems for calibrating epigenetic partitioning assays
|
|
US2020075124A1
|
|
Methods and systems for detecting allelic imbalance in cell-free nucleic acid samples
|
|
WO2020047553A1
|
|
Genetic variant detection based on merged and unmerged reads
|
|
AU2019331907A1
|
|
Methods and systems for detecting contamination between samples
|
|
AU2019328344A1
|
|
Microsatellite instability detection in cell-free DNA
|
|
AU2019310041A1
|
|
Methods and systems for adjusting tumor mutational burden by tumor fraction and coverage
|
|
WO2020006369A1
|
|
Methods and systems for analysis of ctcf binding regions in cell-free dna
|
|
EP3802878A1
|
|
Methods and systems for determining the cellular origin of cell-free nucleic acids
|
|
US2019316185A1
|
|
Systems and methods to detect rare mutations and copy number variation
|
|
AU2019252947A1
|
|
Methods for detecting and suppressing alignment errors caused by fusion events
|
|
US2019287648A1
|
|
Methods for the non-invasive detection and monitoring of therapeutic nucleic acid constructs
|
